Innovator 20 Year Treasury Bond 5 Floor ETF - July (BATS: TFJL)

Innovator 20 Year Treasury Bond 5 Floor ETF - July (BATS:TFJL), Quote.Headers.trade-ideas

The Fund invests at least 80 percent of its net assets in FLexible EXchange Options (FLEX Options) that reference the iShares 20+ Year Treasury Bond ETF (the Underlying ETF). FLEX Options are exchange-traded options contracts with uniquely customizable terms. Although guaranteed for settlement by the Options Clearing Corporation (the OCC), FLEX Options are still subject to counterparty risk with the OCC and may be less liquid than more traditional exchange-traded options. Due to the unique mechanics of the Funds strategy, the return an investor can expect to receive from an investment in the Fund has characteristics that are distinct from many other investment vehicles. It is important that an investor understand these characteristics before making an investment in the Fund.

Innovator 20+ Year Treasury Bond 5 Floor ETF - Quarterly

Innovator 20 Year Treasury Bond 5 Floor ETF - July

WIIM

MBRX

Moleculin Biotech shares are trading higher after the company presented data on Annamycin at IASLC 2024, showing significant tumor growth inhibition and the extended survival of lung cancer with 100% non-cardiotoxicity.

Cantor Fitzgerald analyst Deepak Mathivanan reiterates eBay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) with a Neutral and maintains $62 price target.

News

Price Target

Reiteration

Analyst Ratings

EBAY

Cantor Fitzgerald Reiterates Neutral on eBay, Maintains $62 Price Target

JP Morgan analyst Richard Choe maintains SBA Comms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBAC#NASDAQ">SBAC</a>) with a Neutral and raises the price target from $228 to $250.

SBAC

JP Morgan Maintains Neutral on SBA Comms, Raises Price Target to $250

Oppenheimer analyst Jay Olson upgrades Marinus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNS#NASDAQ">MRNS</a>) from Perform to Outperform and announces $6 price target.

Upgrades

MRNS

Oppenheimer Upgrades Marinus Pharma to Outperform, Announces $6 Price Target

Market Summary

General

Benzinga Market Summary: Oil Rises Amid Middle East Tensions, Bernstein Downgrades GM Stock, Novo Nordisk Falls On Pricing Criticism From Sen. Sanders

FRGT

Freight Technologies shares are trading lower after the company announced a 1-for-25 reverse stock split.

JP Morgan analyst Michael Rehaut maintains Lennar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) with a Neutral and raises the price target from $154 to $173.

JP Morgan Maintains Neutral on Lennar, Raises Price Target to $173

Oppenheimer analyst Ittai Kidron reiterates Atlassian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) with a Outperform and maintains $230 price target.

TEAM

Oppenheimer Reiterates Outperform on Atlassian, Maintains $230 Price Target

Cantor Fitzgerald analyst Deepak Mathivanan reiterates DoorDash (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) with a Overweight and maintains $160 price target.

DASH

Cantor Fitzgerald Reiterates Overweight on DoorDash, Maintains $160 Price Target

Ideaya Biosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDYA#NASDAQ">IDYA</a>), a precision medicine oncology company, released interim Phase 2 <a href="https://www.benzinga.com/pressreleases/24/09/n40975957/ideaya-biosciences-announces-positive-interim-phase-2-data-for-darovasertib-and-successful-fda-typ">clinical trial data</a>.
The data centers on darovasertib in neoadjuvant (therapy before surgery) for uveal melanoma (UM) and an FDA Type C meeting on registrational trial design for regulatory approval in neoadjuvant UM. 
Uveal melanoma is the most common type of eye cancer in adults. Darovasertib is currently being evaluated in four ongoing clinical trials, two of which are in collaboration with Pfizer Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>).
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/07/39670897/ideaya-biosciences-highlights-encouraging-preliminary-efficacy-safety-profile-for-patients-with-h" rel="noreferrer noopener">IDEAYA Biosciences Highlights &#8216;Encouraging&#8217; Preliminary Efficacy, Safety Profile For Patients With Hard-To-Treat Cancer</a>.
The report shows:
<ul>
<li>Approximately 49% of patients demonstrated greater than 30% tumor shrinkage and approximately 61% eye preservation rate for enucleation patients. </li>
<li>Darovasertib data show that approximately 49% of patients demonstrate greater than 30% tumor shrinkage and approximately 61% eye preservation rate for enucleation patients.</li>
<li>Around 59% of patients showed greater than 20% ocular tumor shrinkage.</li>
</ul>
Ideaya is targeting to initiate a potential registration-enabling Phase 3 randomized clinical trial in neoadjuvant UM patients following finalization of the clinical protocol with the FDA. 
The randomized Phase 3 clinical trial design incorporates guidance and feedback from the U.S. FDA following a recent Type C meeting.&nbsp;
In the Phase 3 clinical trial, the company projects that approximately 400 patients will be randomized to receive darovasertib in either the treatment arm or the control arm, with potential modifications pending further FDA feedback.
Price Action: Ideaya stock is down 5.3% at $33.14 per share at last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/09/40977596/latest-trial-setback-for-astrazenecas-dato-dxd-the-drug-fails-to-extend-lives-of-pretreated-breas" target="_blank" rel="noreferrer noopener">Latest Trial Setback For AstraZeneca&#8217;s Dato-DXd, The Drug Fails To Extend Lives Of Pretreated Breast Cancer Patients</a>.</li>
</ul>

Biotech

Health Care

Movers

Trading Ideas

IDYA

Ideaya Biosciences Stock Tumbles Despite Promising Data From Rare Eye Cancer Candidate

<h3 class="wp-block-heading">When Can We Take Profits?&nbsp;</h3>
On Friday morning, I got a question from a subscriber:&nbsp;
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">Where does this need to go to make the trade profitable? Current stock is $201.33
</blockquote>
The trade he was referring to was&nbsp;<a href="https://portfolioarmor.substack.com/p/trade-alert-small-cap-industrial">our call spread</a>&nbsp;on&nbsp;Powell Industries, Inc. &nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWL#NASDAQ">POWL</a>). That&#8217;s a small cap industrial that&#8217;s essentially a picks &amp; shovels play on increased demand for energy.&nbsp;
<figure class="wp-block-image aligncenter size-full is-resized"><a href="https://portfolioarmor.substack.com/p/trade-alert-small-cap-industrial"><img loading="lazy" decoding="async" width="837" height="766" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/09/21082514/POWL-.jpg" alt="" class="wp-image-1367" style="width:624px" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/09/21082514/POWL-.jpg 837w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/09/21082514/POWL--300x275.jpg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/09/21082514/POWL--768x703.jpg 768w" sizes="(max-width: 837px) 100vw, 837px" /></a><figcaption class="wp-element-caption">Click on the factory to go to the post.</figcaption></figure>
Our trade on POWL last month was a vertical spread expiring on December 20th, buying the $185 strike calls and selling the $190 strike calls, for a net debit of $1.60. If the stock closes above $190 on December 20th, that spread will expire at its maximum value of $5. In that case, we will have made a 213% gain on the $1.60 we paid for it.&nbsp;
My answer to my subscriber was that we could exit our POWL trade now for a profit. But we&#8217;d probably only get close to a 100% gain on it. That&#8217;s because we were so far from the expiration date. That&#8217;s really the main con of call spreads.&nbsp;
<h3 class="wp-block-heading">The Pros And Cons Of Call Spreads</h3>
The main con here is that the short call leg reduces your gains if you try to sell it early. Even though POWL closed at&nbsp;$206.34&nbsp;on Friday&#8211;well above the price where our max again occurs ($190), we wouldn&#8217;t be able to sell this call spread for a net credit of $5 today. We might be able to sell it for $3.20 (which would still be a 100% gain on the $1.60 we paid). But if we want the full, 200%+ gain, we need to hope the stock stays above $190 until we get closer to that December expiration date.&nbsp;
<h3 class="wp-block-heading">So Why Do Call Spreads?</h3>
The first pro of call spreads is that, like other options trades, you can make a lot more money than a shareholder on the same movement in the underlying stock. When we entered our call spread on Powell Industries, on August 13th, the stock was trading at about $162. It only needs to be trading 17% higher than that on December 20th, for us to make more than 200% on this trade.&nbsp;
The second pro of call spreads is that they are cheaper than just buying a call option. That&#8217;s particularly true when you&#8217;re dealing with stocks that have high dollar prices per share. Just buying the $190 strike calls on Powell Industries last month, might have cost over $20 per contract, but with the call spread, we knocked that down to $1.60.&nbsp;
Finally, another pro of call spreads is that having a short leg of the trade helps you avoid IV crush when you are betting on a stock shortly before it releases earnings. Implied volatility drops after earnings releases, lowering the value of options expiring soon after. But with a call spread, IV crush lowering the value of the short call can offset the impact of it lowering the value of your long call.&nbsp;
<h3 class="wp-block-heading">A Great Tool If You&#8217;re Aware Of The Pros And Cons</h3>
Call spreads are a great tool to have in your trading tool box, as long as you&#8217;re aware of the tradeoffs. In the case of Powell Industries, the reason we went out to December 20th with that trade was because the next time the company releases earnings is in early December. And December 20th was the soonest expiration afterwards. Given the company&#8217;s attractive valuation and macro tailwinds with energy demand, there&#8217;s a good chance we&#8217;ll get close to a max profit on this trade.&nbsp;
If you want a heads up when we place a trade on the next name we find with similar characteristics to Powell Industries, feel free to subscribe to our trading Substack/occasional email list below.&nbsp;
If you&#8217;d like to stay in touch
You can scan for optimal hedges for individual securities, find our current top ten names, and&nbsp;create hedged portfolios&nbsp;on&nbsp;<a href="https://portfolioarmor.com/">our website</a>.&nbsp;You can also follow Portfolio Armor on X&nbsp;<a href="https://twitter.com/portfolioarmor">here</a>, or become a free subscriber to our trading Substack using the link below (we&#8217;re using that for our occasional emails now).
<figure class="wp-block-image aligncenter size-full is-resized"><img loading="lazy" decoding="async" width="602" height="418" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/09/21082631/Widget-1.jpg" alt="" class="wp-image-1368" style="width:602px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/09/21082631/Widget-1.jpg 602w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/09/21082631/Widget-1-300x208.jpg 300w" sizes="(max-width: 602px) 100vw, 602px" /></figure>
And you can hedge your long positions using our&nbsp;<a href="https://apps.apple.com/us/app/portfolio-armor/id394951144">optimal hedging app</a>.&nbsp;

Options

Opinion

Markets

POWL

The Pros And Cons Of Call Spreads

-2024 Bank of America European Autos and Future Car Virtual Conference&nbsp;&nbsp;&nbsp;&nbsp;

STLA

Stellantis CFO Says Our Target Is To Cut Inventories In North America By 100,000 Units By Start Of 2025

Cantor Fitzgerald analyst Deepak Mathivanan reiterates Maplebear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CART#NASDAQ">CART</a>) with a Overweight and maintains $45 price target.

CART

Cantor Fitzgerald Reiterates Overweight on Maplebear, Maintains $45 Price Target

High-performance, compact power supply family meets stringent medical equipment safety standards without custom designs
Advanced Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEIS#NASDAQ">AEIS</a>) – a global leader in highly engineered, precision power conversion, measurement and control solutions – has announced the NCF150 series of high-isolation, low-leakage current AC-DC power supplies that enable medical equipment designers to meet the cardiac floating (CF) requirements of the IEC 60601-1 medical safety standard using off-the-shelf products.
Type CF is the most stringent medical electrical safety classification and is essential for medical products that may come in direct contact with the heart, including dialysis machines, cardiac-related systems and platforms for electrosurgery. With the launch of its SL Power NCF150 series of CF-rated AC-DC power supplies, Advanced Energy now offers standard, compact products that combine the performance and reliability demanded by complex medical systems with the high isolation voltage and low leakage current essential for CF certification.
 &nbsp;

AEIS

Advanced Energy Launches World's First Off-The-Shelf Convection Cooled CF-Rated Standard Power Supplies which Meets Stringent Medical Equipment Safety Standards Without Custom Designs

Cantor Fitzgerald analyst Deepak Mathivanan reiterates Booking Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>) with a Neutral and maintains $3590 price target.

BKNG

Cantor Fitzgerald Reiterates Neutral on Booking Holdings, Maintains $3590 Price Target

Treasure Global Shares Resume Trade

KAVL

Kaival Brands Innovations Group Shares Resume Trading

Cantor Fitzgerald analyst Deepak Mathivanan reiterates Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Overweight and maintains $230 price target.

AMZN

Cantor Fitzgerald Reiterates Overweight on Amazon.com, Maintains $230 Price Target

Investors with a lot of money to spend have taken a bearish stance on Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ANET, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 10 options trades for Arista Networks.
This isn't normal.
The overall sentiment of these big-money traders is split between 40% bullish and 50%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $81,600, and 9, calls, for a total amount of $701,394.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $350.0 to $400.0 for Arista Networks over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Arista Networks's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Arista Networks's significant trades, within a strike price range of $350.0 to $400.0, over the past month.
<h3>Arista Networks Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727100098_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/27/24</td>
<td>$33.4</td>
<td>$29.9</td>
<td>$32.0</td>
<td>$355.00</td>
<td>$288.0K</td>
<td style="text-align: right;">348</td>
<td style="text-align: right;">100</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$19.0</td>
<td>$18.1</td>
<td>$18.41</td>
<td>$380.00</td>
<td>$138.0K</td>
<td style="text-align: right;">502</td>
<td style="text-align: right;">170</td>
</tr>
<tr>
<td>ANET</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$40.8</td>
<td>$39.9</td>
<td>$40.8</td>
<td>$390.00</td>
<td>$81.6K</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>10/25/24</td>
<td>$15.0</td>
<td>$13.2</td>
<td>$14.2</td>
<td>$390.00</td>
<td>$71.0K</td>
<td style="text-align: right;">83</td>
<td style="text-align: right;">50</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$50.6</td>
<td>$49.1</td>
<td>$49.7</td>
<td>$360.00</td>
<td>$49.7K</td>
<td style="text-align: right;">380</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>

<h3>About Arista Networks</h3>
Arista Networks is a networking equipment provider that primarily sells Ethernet switches and software to data centers. Its marquee product is its extensible operating system, or EOS, that runs a single image across every single one of its devices. The firm operates as one reportable segment. It has steadily gained market share since its founding in 2004, with a focus on high-speed applications. Arista counts Microsoft and Meta Platforms as its largest customers and derives roughly three quarters of its sales from North America.
Having examined the options trading patterns of Arista Networks, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of Arista Networks</h3>
<ul>
<li>With a volume of 193,912, the price of ANET is down -0.32% at $383.23. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 35 days.</li>
</ul>
<h3>What The Experts Say On Arista Networks</h3>
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $384.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Evercore ISI Group keeps a Outperform rating on Arista Networks with a target price of $400. 
&#x2A; An analyst from UBS persists with their Neutral rating on Arista Networks, maintaining a target price of $369. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Arista Networks with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

ANET

Decoding Arista Networks's Options Activity: What's the Big Picture?

<a href="https://hntrbrk.com/winnebago/" title="https://hntrbrk.com/winnebago/">https://hntrbrk.com/winnebago/</a>

Short Sellers

Watching Winnebago Industries; Hunterbrook Issues Report On Co Titled ""Grand Deception" — Winnebago Muzzles Outcry Over Major Problem That Owners Say Makes RVs Dangerous, Untowable, Worthless"

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Innovator 20 Year Treasury Bond 5 Floor ETF - July

Overview

Innovator 20 Year Treasury Bond 5 Floor ETF - July (BATS:TFJL), Quote.Headers.trade-ideas